Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men (Q70867004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

1 reference

Goldberg MR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

de Mey C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

Wroblewski JM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

Li Q

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

Schroeter V

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

Belz GG

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

72-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology of Nonpeptide Angiotensin II Receptor Antagonists

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Angiotensin II receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990026-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(96)90026-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8549037%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference